key: cord-0793965-iz1fy8hc
authors: Nawwar, Ayah Adel; Searle, Julie; Hopkins, Richard; Lyburn, Iain Douglas
title: False-Positive Axillary Lymph Nodes on FDG PET/CT Resulting From COVID-19 Immunization
date: 2021-04-21
journal: Clin Nucl Med
DOI: 10.1097/rlu.0000000000003657
sha: 798103e2beef1994e89cb26bc0f6ca7a48f64e50
doc_id: 793965
cord_uid: iz1fy8hc

World-wide mass COVID-19 vaccination has been deployed starting with those most vulnerable, including the elderly and cancer patients. A 70-year-old man with right lung cancer underwent staging FDG PET/CT, which demonstrated an avid right lung mass with avid hilar and mediastinal nodes. Avid left axillary nodes of benign configuration were also noted. The patient had the Oxford-AstraZeneca COVID-19 vaccination in the left arm a week earlier. On reflection, the axillary nodes were concluded to be reactive related to this. This is a potential COVID-19 vaccination associated pitfall on PET/CT that should be considered when interpreting FDG PET/CT images.

A 70-year-old man with right lung cancer. A half-body (skull base to mid-thigh) staging FDG PET/CT scan to assess disease extent; MIP (A) demonstrated a markedly avid right lung apical mass and avid ipsilateral hilar and mediastinal nodes. Contralateral axillary nodes of a similar avidity were also noted (arrow). These are clearly demonstrated on the axial CT, PET, and fused PET/CT (B-D). This raised the suspicion of nodal involvement. On CT correlation, the left axillary nodes had a benign configuration. It was noted that the tracer was administered via the right antecubital fossa and hence unlikely to be related. 1 The patient, however, gave history of Oxford-AstraZeneca COVID-19 vaccination in the left upper arm 1 week earlier as part of the current mass vaccination program. FDG PET/CT can identify disease within nonenlarged lymph nodes; however, nonmalignant causes of avid nodes are also identified, such as reactive nodes in response to infection or inflammation. 2 Axillary lymphadenopathy has been found associated with various vaccinations on FDG PET/CT, such as vaccinations for H1N1, human papilloma virus, and influenza. [3] [4] [5] [6] On reviewing, the CT component and correlating with the clinical history, it was concluded that the left axillary nodes were reactive, in response to recent ipsilateral vaccination. Similar findings were recently described associated with COVID-19 mRNA vaccines (Pfizer-BioNTech). 7, 8 This highlights a new pitfall related to the current mass COVID-19 vaccination that PET/CT reporters should be aware of. If it is not considered, this may result in inadvertent upstaging and overtreatment; in this case, PET/CT staging could have been potentially escalated from M0 to M1b. 9 

Causes and imaging features of false positives and false negatives on F-PET/CT in oncologic imaging

Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants

Incidence and intensity of F-18 FDG uptake after vaccination with H1N1 vaccine

False-positive axillary lymph node on FDG-PET/CT scan resulting from immunization

Lymph node activation by PET/CT following vaccination with licensed vaccines for human papillomaviruses

Axillary lymph node accumulation on FDG-PET/CT after influenza vaccination

Imaging of COVID-19 vaccination at FDG PET/CT. Radiology

COVID-19 mRNA vaccination-induced lymphadenopathy mimics lymphoma progression on FDG PET/CT

The new 8th TNM staging system of lung cancer and its potential imaging interpretation pitfalls and limitations with CT image demonstrations